ScreenerHero vs Stockopedia
Stockopedia charges €80/month
for US + Europe. We charge €29.
Stockopedia's US + European plan costs €80/month — and doesn't include Canada. ScreenerHero covers US, Canada, and all of Europe, including microcaps, for €29/month. With a free tier that requires no account.
Stockopedia US+EU
€80/mo
ScreenerHero Pro
€29/mo
TL;DR
If you want a score-driven workflow with editorial context, Stockopedia is well-built for that — at €60–€80/mo. If you want to apply your own filters to US, Canadian, and European stocks including microcaps, ScreenerHero does it for €29/mo with a free tier that needs no account.
At a glance
| Feature | ScreenerHero | Stockopedia |
|---|---|---|
| US stocks | Yes — full coverage | US+EU plan only — €80/mo |
| Canadian stocks | Yes | No |
| European stocks (incl. microcaps) | Full — all active instruments | EU plan — UK-weighted, gaps in continental EU |
| Price | €29/mo · €240/yr (€20/mo) | €60/mo EU · €80/mo US+EU |
| Free tier | Yes — no account required | No — 14-day trial only |
| Screener filters | P/E, P/B, ROE, EV/EBITDA, margins, beta, momentum | StockRanks composite + limited custom filters |
| UI density | Desktop-first, data-dense tables | Card-based, narrative-oriented |
| Proprietary scoring | No — raw data, your criteria | Yes — StockRanks (Quality + Value + Momentum) |
| Heatmap | Yes — sector heatmap | Limited |
| Data freshness | EOD | EOD |
Where the differences actually matter
Coverage — US, Canada, and European microcaps
Stockopedia's European plan covers UK and Europe for €60/month but excludes the US entirely. To add US coverage, you pay €80/month — and Canada is still not included at any price point.
ScreenerHero covers US, Canada, and all of Europe in a single plan at €29/month. European coverage includes all active instruments on BME, Euronext Paris, XETRA, and Borsa Italiana — including microcaps and illiquid names that most tools skip. Where fundamental data is missing for illiquid names, it is shown explicitly rather than hidden.
Price — €80/mo vs €29/mo
Stockopedia's US + Europe plan costs €80/month (€64/month billed annually). The Europe-only plan is €60/month. Neither includes Canada.
ScreenerHero Pro is €29/month — or €20/month billed annually at €240/year. The free tier is permanent and requires no account — you can evaluate data quality across US, Canadian, and European names before paying anything.
Screener workflow — raw filters vs scored ranks
Stockopedia's core innovation is StockRanks: a composite percentile for quality, value, and momentum. It is well-built and useful if you trust the methodology and want a guided shortcut to stock ideas.
ScreenerHero exposes raw metrics — P/E, P/B, ROE, EV/EBITDA, profit margin, beta, dividend yield, and momentum — and lets you filter and sort by any combination across US, Canadian, and European stocks simultaneously. If your strategy has specific thresholds, this is faster. If you prefer a guided composite score, Stockopedia is the better fit.
UI — dense data tables vs narrative cards
Stockopedia wraps data in editorial commentary and a card-based layout. This works for investors who want explanatory context alongside the numbers.
ScreenerHero is built desktop-first for analysis sessions of 30–90 minutes. The interface is dense, data-first, and optimised for speed — similar to Finviz but with global coverage. If you already know what you're looking for and want to filter a large multi-market universe fast, that design difference matters.
ScreenerHero is the better fit if…
- Investors who screen US, Canadian, and European stocks in one workflow
- Anyone covering European small and microcap names most tools ignore
- Analysts who want dense, fast tables — not narrative summaries
- Users who need a serious tool without paying €80/mo before knowing if it fits
- Investors who prefer raw metrics over composite scores
Stockopedia is the better fit if…
- Investors who prefer a score-driven workflow (StockRanks)
- UK-focused investors who want editorial context alongside data
- Beginners who want a structured framework rather than raw filters
- Investors willing to pay €60–€80/mo for curated quality/value/momentum rankings
Common questions when switching
Does ScreenerHero replace Stockopedia's StockRanks?
No. There is no composite score in ScreenerHero — it is built for investors with their own criteria who want to apply those criteria to a clean dataset across US, Canadian, and European markets.
Does ScreenerHero cover the same European stocks as Stockopedia?
ScreenerHero covers all active instruments on major European exchanges including BME, Euronext Paris, XETRA, and Borsa Italiana — including illiquid and microcap names. Stockopedia's European coverage is strongest in UK equities and can have gaps in continental small caps.
Can I try ScreenerHero before committing?
Yes — the screener is open without any login. Run your filters across US, Canadian, and European stocks, check coverage on the names you follow, and decide. No trial period, no time limit on the free tier.
How does annual pricing compare?
Stockopedia's annual plans are €48/mo (EU only) and €64/mo (US+EU). ScreenerHero Pro annual is €20/month — billed as €240/year. That is €240 versus €768 for comparable global coverage.
Try ScreenerHero free — no account needed
Filter US, Canadian, and European stocks by P/E, ROE, P/B, EV/EBITDA, and more. Free, no signup. Pro at €29/month when you need alerts and saved presets.